Thyroid Cancer Inoperable: A place for Thyroid RFA to relieve symptoms and shrink the tumor.

Thyroid Cancer Inoperable: A place for Thyroid RFA to relieve symptoms and shrink the tumor.

Thyroid Cancer Inoperable: A place for Thyroid RFA to relieve symptoms and shrink the tumor.
    Thyroid Cancer Inoperable: A place for Thyroid RFA to relieve                    symptoms and shrink the tumor.Dr.Guttler’s comments:

  1. 16 cases treated with RFA under local anesthesia.
  2. Tumor volume was 9 ml ( 0.1-34 )
  3. 6/16 complete ablation.
  4. 1/16 failed.
  5. 13/15 reduced in size.
  6. 2/15 regrowth.
  7. Volume reduction was 51% ( -9-97% )
  8. 7/15 had symptom relief.
  9. No major complications.1/16 had skin burn.
  10. If you have thyroid cancer and reached the point that surgery is not an option consider thyroid RF.
  11. Call for details 310393-8860 or email to [email protected]
  12. Dr.G.

 

Inoperable Symptomatic Recurrent Thyroid Cancers: Preliminary Result of Radiofrequency Ablation

Purpose

To determine the role of radiofrequency ablation (RFA) in patients with inoperable symptomatic recurrent thyroid cancers.

Materials and Methods

Eleven patients with 16 symptomatic recurrent thyroid cancers but ineligible for surgery were prospectively enrolled and underwent ultrasound-guided RFA with local anesthesia in 16 sessions. The mean tumor volume and diameter were 9 ml (range 0.1–34 ml) and 2.9 cm (range 0.7–4.8 cm), respectively. Patients had dysphagia, hoarseness, dyspnea, or a protruding mass due to recurrent tumors. Tumor volume was calculated from follow-up ultrasound, and symptoms were assessed after RFA.

Results

Of 16 sessions, tumor ablation was complete in 6, incomplete in 9, and failed in 1. Incomplete or failed ablation was due to intolerable pain, severe calcified lesion, or tumor encasement of major vessels. Of 15 treated lesions, 13 decreased in volume. Regrowth of treated tumors was observed in 2 lesions. The mean volume reduction was 50.9% (range −9.4 to 96.8%). There were gains for symptom relief for 7 patients (63.6%) with protruding masses (n = 6) and discomfort due to tracheal compression (n = 1). The mean follow-up was 6 months (1–14 months). There were no major complications except a patient with skin burn.

recurrent-cancer

Cancer stable at 5 years after RFA.

Conclusion

RFA is feasible and safe, and can improve symptoms in the short term.

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860